This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Liang, X.-J. Articles by Gottesman, M. M. Search for Related Content PubMed PubMed Citation Articles by Liang, X.-J. Articles by Gottesman, M. M.

Mislocalization of Membrane Proteins Associated with Multidrug Resistance in Cisplatin-resistant Cancer Cell Lines¹

Laboratory of Cell Biology [X-J. L., D-W. S., M. M. G.] and Laboratory of Experimental Carcinogenesis [S. G.], Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-4254

The accumulation of [¹⁴C]carboplatin and [³H]methotrexate is reduced in single-step KB epidermoid adenocarcinoma (KB-CP) cells, which are cross-resistant to carboplatin, methotrexate, and sodium arsenite. In these KB-CP cells, multidrug resistance is accompanied by mislocalization of multidrug resistance associated protein (MRP) 1 and other membrane proteins such as folate-binding protein. MRP1 was not decreased in amount in single-step variants but accumulates in a cytoplasmic fraction, and its apparent molecular weight was altered probably because of reduced glycosylation in resistant cells. This low-density compartment was partially labeled with antibodies to lectin-GSII (a Golgi marker) and Bip/GRP78 (an endoplasmic reticulum marker). Pulse-chase labeling of MRP1 with ³⁵S-methionine and ³⁵S-cysteine and pulse-chase biotinylation of cell surface MRP1 suggests that membrane protein mislocalization is caused mainly by a defect of plasma membrane protein recycling, manifested also as a defect in acidification of lysosomes. The reduced accumulation of cytotoxic compounds in the KB-CP cells is presumed to result from the failure of carrier proteins and/or transporters to localize to the plasma membrane.

This article has been cited by other articles:

				W. Lee, A. Belkhiri, A. C. Lockhart, N. Merchant, H. Glaeser, E. I. Harris, M. K. Washington, E. M. Brunt, A. Zaika, R. B. Kim, et al. Overexpression of OATP1B3 Confers Apoptotic Resistance in Colon Cancer Cancer Res., December 15, 2008; 68(24): 10315 - 10323. [Abstract] [Full Text] [PDF]

				J. Mishra, Q. Zhang, J. L. Rosson, J. Moran, J. M. Dopp, and B. L. Neudeck Lipopolysaccharide Increases Cell Surface P-glycoprotein That Exhibits Diminished Activity in Intestinal Epithelial Cells Drug Metab. Dispos., October 1, 2008; 36(10): 2145 - 2149. [Abstract] [Full Text] [PDF]

				X.-J. Liang, T. Finkel, D.-W. Shen, J.-J. Yin, A. Aszalos, and M. M. Gottesman SIRT1 Contributes in Part to Cisplatin Resistance in Cancer Cells by Altering Mitochondrial Metabolism Mol. Cancer Res., September 1, 2008; 6(9): 1499 - 1506. [Abstract] [Full Text] [PDF]

				F. Yu, J. Megyesi, and P. M. Price Cytoplasmic initiation of cisplatin cytotoxicity Am J Physiol Renal Physiol, July 1, 2008; 295(1): F44 - F52. [Abstract] [Full Text] [PDF]

				D.-W. Shen, X.-J. Liang, T. Suzuki, and M. M. Gottesman Identification by Functional Cloning from a Retroviral cDNA Library of cDNAs for Ribosomal Protein L36 and the 10-kDa Heat Shock Protein that Confer Cisplatin Resistance Mol. Pharmacol., April 1, 2006; 69(4): 1383 - 1388. [Abstract] [Full Text] [PDF]

				J. C. Valencia, H. Watabe, A. Chi, F. Rouzaud, K. G. Chen, W. D. Vieira, K. Takahashi, Y. Yamaguchi, W. Berens, K. Nagashima, et al. Sorting of Pmel17 to melanosomes through the plasma membrane by AP1 and AP2: evidence for the polarized nature of melanocytes J. Cell Sci., March 15, 2006; 119(6): 1080 - 1091. [Abstract] [Full Text] [PDF]

				X.-J. Liang, S. Mukherjee, D.-W. Shen, F. R. Maxfield, and M. M. Gottesman Endocytic Recycling Compartments Altered in Cisplatin-Resistant Cancer Cells Cancer Res., February 15, 2006; 66(4): 2346 - 2353. [Abstract] [Full Text] [PDF]

				R. Safaei, B. J. Larson, T. C. Cheng, M. A. Gibson, S. Otani, W. Naerdemann, and S. B. Howell Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells Mol. Cancer Ther., October 1, 2005; 4(10): 1595 - 1604. [Abstract] [Full Text] [PDF]

				C. J. Westlake, S. P.C. Cole, and R. G. Deeley Role of the NH2-terminal Membrane Spanning Domain of Multidrug Resistance Protein 1/ABCC1 in Protein Processing and Trafficking Mol. Biol. Cell, May 1, 2005; 16(5): 2483 - 2492. [Abstract] [Full Text] [PDF]

				R. Safaei, K. Katano, B. J. Larson, G. Samimi, A. K. Holzer, W. Naerdemann, M. Tomioka, M. Goodman, and S. B. Howell Intracellular Localization and Trafficking of Fluorescein-Labeled Cisplatin in Human Ovarian Carcinoma Cells Clin. Cancer Res., January 15, 2005; 11(2): 756 - 767. [Abstract] [Full Text] [PDF]

				D.-W. Shen, X.-J. Liang, M. A. Gawinowicz, and M. M. Gottesman Identification of Cytoskeletal [14C]Carboplatin-Binding Proteins Reveals Reduced Expression and Disorganization of Actin and Filamin in Cisplatin-Resistant Cell Lines Mol. Pharmacol., October 1, 2004; 66(4): 789 - 793. [Abstract] [Full Text] [PDF]

				X.-J. Liang, D.-W. Shen, and M. M. Gottesman Down-Regulation and Altered Localization of {gamma}-Catenin in Cisplatin-Resistant Adenocarcinoma Cells Mol. Pharmacol., May 1, 2004; 65(5): 1217 - 1224. [Abstract] [Full Text]